Literature DB >> 7649232

The first known use of vermillion.

J Martín-Gil1, F J Martín-Gil, G Delibes-de-Castro, P Zapatero-Magdaleno, F J Sarabia-Herrero.   

Abstract

Vermillion has been shown to be useful in preserving human bones from 5000 years ago. Remarkably well-preserved human bones have been found in the dolmenic burial 'La Velilla' in Osorno (Palencia, Spain), carefully covered by pulverized cinnabar (vermillion) which ensured their preservation even in non-favorable climatic conditions. We believe the red powder was deliberately deposited for preservative use because no cinnabar mine is to be found within 160 km, because of the large amount (hundreds of kilograms) used, and because its composition, red mercuric sulphide, is similar to that of preparations used in technical embalming. This finding pushes back the data of the use of mercury ore for preservation by four millennia in South America, and by at least one millennium in the Old World. Chemical and thermal analyses of vermillion in La Velilla have demonstrated its great purity and shown that the cinnabar was pulverized and washed (but not heated), producing a bright red-orange tone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649232     DOI: 10.1007/bf01922425

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  3 in total

Review 1.  Human body preservation - old and new techniques.

Authors:  Erich Brenner
Journal:  J Anat       Date:  2014-01-18       Impact factor: 2.610

2.  Chronic mercury exposure in Late Neolithic/Chalcolithic populations in Portugal from the cultural use of cinnabar.

Authors:  Steven D Emslie; Rebecka Brasso; William P Patterson; António Carlos Valera; Ashley McKenzie; Ana Maria Silva; James D Gleason; Joel D Blum
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

3.  New insights on commemoration of the dead through mortuary and architectural use of pigments at Neolithic Çatalhöyük, Turkey.

Authors:  E M J Schotsmans; G Busacca; S C Lin; M Vasić; A M Lingle; R Veropoulidou; C Mazzucato; B Tibbetts; S D Haddow; M Somel; F Toksoy-Köksal; C J Knüsel; M Milella
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.